The leading manufacturer of anti-retroviral medications worldwide is an Indian pharmaceutical business called Hetero Drugs. APIs, generics, biosimilars, branded generics, and custom pharmaceutical services are all part of Hetero's business. Over 21,000 people are employed by the hetero group. Hetero competes in the markets for final doses and active pharmaceutical components. Over 127 nations are where it has a marketing presence. Hetero has provided antiretroviral medications to patients in more than 100 different nations worldwide.
Hetero Drugs, Hetero Labs, Hetero Research Foundation, Genx Laboratories, as well as international companies like Camber Pharma Inc. in the United States, Hetero Europe in Europe, Amarox Pharma Global in Indonesia, and Richmond Labs in Argentina, are among the subsidiaries of the Hetero Group. The company is also making investments in the wind energy sector, hoping to achieve 1,000 megawatts by 2017.